Close

Kamada's (KMDA) Inhaled Alpha-1 Antitrypsin Phase 2 Met Primary Endpoint

Go back to Kamada's (KMDA) Inhaled Alpha-1 Antitrypsin Phase 2 Met Primary Endpoint